Author:
Mazzara Calogero,Bassi Jessica,Silacci-Fregni Chiara,Muoio Francesco,Passini Nadia,Corti Davide,Simonetti Giacomo D.,Vanoni Federica,Kottanattu Lisa,Piccoli Luca
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Naeimi R, Sepidarkish M, Mollalo A, Parsa H, Mahjour S, Safarpour F, Almukhtar M, Mechaal A, Chemaitelly H, Sartip B, Marhoommirzabak E, Ardekani A, Hotez PJ, Gasser RB, Rostami A (2023) SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis. EClinicalMedicine 56:101786
2. Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP (2021) Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 27:1205–1211
3. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(281–292):e286
4. Dunay GA, Barroso M, Woidy M, Danecka MK, Engels G, Hermann K, Neumann FS et al (2023) Long-term antibody response to SARS-CoV-2 in children. J Clin Immunol 43:46–56
5. Jacobsen EM, Fabricius D, Class M, Topfstedt F, Lorenzetti R, Janowska I, Schmidt F et al (2022) High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection. Nat Commun 13:7315